Cargando…

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)

BACKGROUND: A previous study has documented the reliability and validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in exploring patient satisfaction with medicines for chronic health conditions in routine medical practice, but the minimally important difference (MID) of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rejas, Javier, Ruiz, Miguel A, Pardo, Antonio, Soto, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241617/
https://www.ncbi.nlm.nih.gov/pubmed/22014277
http://dx.doi.org/10.1186/1471-2288-11-142
_version_ 1782219533845528576
author Rejas, Javier
Ruiz, Miguel A
Pardo, Antonio
Soto, Javier
author_facet Rejas, Javier
Ruiz, Miguel A
Pardo, Antonio
Soto, Javier
author_sort Rejas, Javier
collection PubMed
description BACKGROUND: A previous study has documented the reliability and validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in exploring patient satisfaction with medicines for chronic health conditions in routine medical practice, but the minimally important difference (MID) of this tool is as yet unknown. The objective of this research was to estimate the MID for the SATMED-Q total score and six constituent domains. METHODS: The sample of patients (456 subjects, mean age 59 years, 53% male) used for testing psychometric properties was also used to assess MID. Item #14 of the Treatment Satisfaction Questionnaire for Medication (TSQM) was used as an anchor reference since it directly explores satisfaction with medicine on a 7-point ordinal scale (from extremely satisfied to extremely dissatisfied, with a neutral category). Patients were classified into four categories according to responses to this item (extremely satisfied/dissatisfied, very satisfied/dissatisfied, satisfied/dissatisfied, neither satisfied nor dissatisfied (neutral), and calculations were made for the total score and each domain of the SATMED-Q using standardised scores. The mean absolute differences in total score (and domains) between the neutral category and the satisfied/dissatisfied category were considered to be the MID. Effect sizes (ES) were also computed. RESULTS: The MID for the total score was 13.4 (ES = 0.91), while the domain values ranged from 10.3 (medical care domain, ES = 0.43) to 20.6 (impact on daily living, ES = 0.85). Mean differences in satisfaction (as measured by the total SATMED-Q score and domain scores) using the levels of satisfaction established by item #14 were significantly different, with F values ranging from 12.2 to 88.8 (p < 0.001 in all cases). CONCLUSION: The SATMED-Q was demonstrated to be responsive to different levels of patient satisfaction with therapy in chronically ill subjects. The MID obtained was 13.4 points for the overall normalised scoring scale, and between 10.3 and 20.6 points for domains.
format Online
Article
Text
id pubmed-3241617
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32416172011-12-17 Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) Rejas, Javier Ruiz, Miguel A Pardo, Antonio Soto, Javier BMC Med Res Methodol Research Article BACKGROUND: A previous study has documented the reliability and validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in exploring patient satisfaction with medicines for chronic health conditions in routine medical practice, but the minimally important difference (MID) of this tool is as yet unknown. The objective of this research was to estimate the MID for the SATMED-Q total score and six constituent domains. METHODS: The sample of patients (456 subjects, mean age 59 years, 53% male) used for testing psychometric properties was also used to assess MID. Item #14 of the Treatment Satisfaction Questionnaire for Medication (TSQM) was used as an anchor reference since it directly explores satisfaction with medicine on a 7-point ordinal scale (from extremely satisfied to extremely dissatisfied, with a neutral category). Patients were classified into four categories according to responses to this item (extremely satisfied/dissatisfied, very satisfied/dissatisfied, satisfied/dissatisfied, neither satisfied nor dissatisfied (neutral), and calculations were made for the total score and each domain of the SATMED-Q using standardised scores. The mean absolute differences in total score (and domains) between the neutral category and the satisfied/dissatisfied category were considered to be the MID. Effect sizes (ES) were also computed. RESULTS: The MID for the total score was 13.4 (ES = 0.91), while the domain values ranged from 10.3 (medical care domain, ES = 0.43) to 20.6 (impact on daily living, ES = 0.85). Mean differences in satisfaction (as measured by the total SATMED-Q score and domain scores) using the levels of satisfaction established by item #14 were significantly different, with F values ranging from 12.2 to 88.8 (p < 0.001 in all cases). CONCLUSION: The SATMED-Q was demonstrated to be responsive to different levels of patient satisfaction with therapy in chronically ill subjects. The MID obtained was 13.4 points for the overall normalised scoring scale, and between 10.3 and 20.6 points for domains. BioMed Central 2011-10-20 /pmc/articles/PMC3241617/ /pubmed/22014277 http://dx.doi.org/10.1186/1471-2288-11-142 Text en Copyright ©2011 Rejas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rejas, Javier
Ruiz, Miguel A
Pardo, Antonio
Soto, Javier
Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title_full Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title_fullStr Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title_full_unstemmed Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title_short Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
title_sort minimally important difference of the treatment satisfaction with medicines questionnaire (satmed-q)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241617/
https://www.ncbi.nlm.nih.gov/pubmed/22014277
http://dx.doi.org/10.1186/1471-2288-11-142
work_keys_str_mv AT rejasjavier minimallyimportantdifferenceofthetreatmentsatisfactionwithmedicinesquestionnairesatmedq
AT ruizmiguela minimallyimportantdifferenceofthetreatmentsatisfactionwithmedicinesquestionnairesatmedq
AT pardoantonio minimallyimportantdifferenceofthetreatmentsatisfactionwithmedicinesquestionnairesatmedq
AT sotojavier minimallyimportantdifferenceofthetreatmentsatisfactionwithmedicinesquestionnairesatmedq